Group 1 - The core viewpoint of the news is the successful listing of four new companies on the A-share market, highlighting the growing acceptance of unprofitable hard-tech companies in the stock market [1][2][3] - Three companies, He Yuan Bio, Xi'an Yicai, and Biobetter, are the first batch of new registered companies in the Sci-Tech Innovation Board's growth tier, which allows unprofitable tech firms to go public [1][2] - The first-day performance of the new stocks was impressive, with significant price increases: Tai Kai Ying rose by 180.27%, He Yuan Bio by 178.91%, Xi'an Yicai by 211.40%, and Biobetter by 82.96% [1] Group 2 - The "1+6" policy announced by the China Securities Regulatory Commission aims to support tech companies with significant breakthroughs and large commercial prospects, even if they are currently unprofitable [2] - He Yuan Bio has eight drug candidates in development, with one product already approved for market, while Biobetter has multiple products at various clinical trial stages [2] - Xi'an Yicai is a leading player in the 12-inch silicon wafer market, ranking first in China and sixth globally based on projected monthly shipments and production capacity by the end of 2024 [2]
4只新股同日上市皆大涨 其中3家为科创板科创成长层首批新注册公司
Sou Hu Cai Jing·2025-10-28 16:23